comparemela.com
  1. Home
  2. Live Updates
  3. Saol Therapeutic - Breaking News

Saol Therapeutic News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Saol Therapeutics Announces First Patient Enrolled in Phase 2 COMPASS Trial Evaluating the Safety and Efficacy Profile of SL-1002 for Treatment of Knee Pain Associated with Osteoarthritis

/PRNewswire/ Saol Therapeutics, a privately held, clinical-stage pharmaceutical company, announced today that the first patient has been enrolled in the.

United statesDavid penakeZachary mccormickMehulj desaiPerformance centerPain performance centerUniversity of utahInternational spineSaol therapeuticsSaol therapeuticSpain trialInvestigator mehulPrincipal investigator zachary mccormickVice chairAssociate professorPhysical medicine

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.